Long-Term Outcomes After Percutaneous Coronary Intervention for Chronic Total Occlusion (from the CREDO-Kyoto Registry Cohort-2)

Erika Yamamoto(Kyoto University), Takeshi Kimura(Municipal Hirakata City Hospital), Yutaka Furukawa(Kobe City Medical Center General Hospital), Kazuaki Mitsudo(Kurashiki Central Hospital), Yoshihisa Nakagawa(Tenri Hospital), Takeshi Morimoto(Hyogo Medical University), Masahiro Natsuaki(Saga University), Masaru Tanaka(Osaka Red Cross Hospital), Masakiyo Nobuyoshi(Kurume University), Koh Ono(Kyoto University), Osamu Doi(Shizuoka General Hospital), Takashi Tamura(Japanese Red Cross Society Wakayama Medical Center)
The American Journal of Cardiology
June 1, 2013
10.1016/j.amjcard.2013.05.004
Cited by 82

Related Papers

Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
|JAMA|2019|830
Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials
|The Lancet|2018|357
JCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery Disease
|Circulation Journal|2020|345
The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease
|Thrombosis and Haemostasis|2020|334
Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome
|JAMA Cardiology|2022|296